Rekvina Laboratories Limited announced audited standalone earnings results for the fourth quarter and year ended March 31, 2018. For the quarter, the company reported revenue from operations of INR 0.075 million against INR 0.107 million a year ago. Loss before exceptional items and tax was INR 0.595 million against INR 0.201 million a year ago. Net loss for the period was INR 0.595 million against INR 0.201 million a year ago. For the year, the company reported revenue from operations of INR 0.193 million against INR 0.284 million a year ago. Loss before exceptional items and tax was INR 0.798 million against INR 0.193 million a year ago. Net loss for the period was INR 0.798 million against INR 0.193 million a year ago.